
MYF-01-37
CAS No. 2416417-65-5
MYF-01-37( 1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one )
Catalog No. M24113 CAS No. 2416417-65-5
MYF-01-37 is a novel covalent TEAD inhibitor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 31 | In Stock |
![]() ![]() |
5MG | 50 | In Stock |
![]() ![]() |
10MG | 87 | In Stock |
![]() ![]() |
25MG | 160 | In Stock |
![]() ![]() |
50MG | 282 | In Stock |
![]() ![]() |
100MG | 421 | In Stock |
![]() ![]() |
500MG | 888 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameMYF-01-37
-
NoteResearch use only, not for human use.
-
Brief DescriptionMYF-01-37 is a novel covalent TEAD inhibitor.
-
DescriptionMYF-01-37 is a novel covalent TEAD inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one
-
PathwayOthers
-
TargetOther Targets
-
RecptorTEAD
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2416417-65-5
-
Formula Weight298.3
-
Molecular FormulaC15H17F3N2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (838.08 mM)
-
SMILESCC(CC1)(CN1C(C=C)=O)Nc1cccc(C(F)(F)F)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kurppa K J , Liu Y , To C , et al. Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway[J]. Cancer Cell, 2020, 37(1):104-122.e12.
molnova catalog



related products
-
Ethofumesate
Ethofumesate, a chiral herbicide, acts by inhibiting mitosis and reducing photosynthesis and plant respiration .
-
Ro 5212773
EPPTB is a selective TAAR1 antagonist.
-
Episyringaresinol
Episyringaresinol is a natural lignan isolated from Kalimeris indica.